Welcome

Advanced Pain and Neuromuscular Consultants of Brevard offers a comprehensive approach for the treatment chronic pain. 

Chronic pain can rule your life, interfering with your ability to work, sleep and enjoy your family and friends. When chronic pain disrupts your quality of life and does not improve with standard treatments , Advanced Pain and Neuromuscular Consultants of Brevard is here to help. 

Advanced Pain and Neuromuscular Consultants of Brevard specialists are Board-certified physicians are dedicated to the goal of helping people with chronic pain return to a normal, productive lifestyle. 

Many of the patients referred to us have been through multiple other treatment options including interventional pain therapy and surgery.  

Our physicians take into account all prior treatment modalities then, utilizing the best of current medical knowledge and technology, we will work with you to identify the source of your pain, then design what they feel will be your most effective pain relief program.

There are many safe, proven effective treatments available that can eliminate or reduce chronic pain. The sooner you seek treatment, the sooner you can start enjoying life again.

We welcome you to come and learn more about our services. Please contact us if you have any additional questions.

Thank you for visiting us!

Medical Staff

Coming Soon!

307 E. New Haven Avenue, Melbourne, FL 32901

307 E. New Haven Avenue
Melbourne, FL 32901

Office: 321.729.8223
Fax: 321.729.6252

Driving Directions

google-map0

8075 Spyglass Hill Road, Viera, FL 32940

8075 Spyglass Hill Road,
Viera, FL 32940

Office: 321.259.8993
Fax: 321.729.6252

Driving directions

google-map1

Latest News

Diabetic Nerve Damage Linked to Metabolic Factors (CME/CE)

(MedPage Today) -- Targeting the various aspects of the metabolic syndrome may provide a means for preventing the development of diabetic neuropathy, authors of a review suggested. Read More

No Charges in Federal Probe of Medtronic Infuse

(MedPage Today) -- The U.S. Department of Justice has closed its probe of Medtronic's marketing of its Infuse bone growth product for spinal fusion surgery without filing charges, the company said. Read More

Distractions Help Cut Pain (CME/CE)

(MedPage Today) -- Distracting the mind not only can take the focus off pain but can actually dampen the body's early physiological response to pain signals by way of endogenous opioids, a small study found. Read More

Hospira Pulls More Opioid Painkiller Vials

(MedPage Today) -- The FDA has announced the recall of one lot of Hospira's hydromorphone hydrochloride injection because of an overdose risk from potentially overfilled vials. Read More

Low Back Pain Eases but Doesn't Vanish (CME/CE)

(MedPage Today) -- Symptoms of acute and persistent low-back pain improved significantly in the first 6 weeks after treatment, but even at 1 year there was lingering chronic pain and disability, a major study by Australian and Brazilian researchers found. Read More

Study Confirms Marijuana Helps in MS (CME/CE)

(MedPage Today) -- Smoking marijuana cuts spasticity and pain that's resistant to conventional therapy in multiple sclerosis, although with some cognitive effects, a small clinical trial affirmed. Read More

MedPage Today/Milwaukee Journal Sentinel Series Triggers Senate Investigation

WASHINGTON (MedPage Today) -- The Senate Finance Committee today sent letters to 10 professional organizations and pharmaceutical companies seeking to clarify the extent of the financial connections between manufacturers of opioid painkillers and the promotion of their use in chronic pain. Read More

Doctors Misread Pain of IUD Placement (CME/CE)

SAN DIEGO (MedPage Today) -- Doctors asked to estimate the pain their patients felt during insertion of an intrauterine contraceptive device didn't even come close, researchers reported here. Read More

Lyrica Fails in Pain Trials

(MedPage Today) -- Pregabalin (Lyrica) was not effective in reducing neuropathic pain associated with HIV infection or diabetes in two separate trials, the drug's manufacturer said. Read More

Vitamin D May Be of Help in Fibromyalgia (CME/CE)

GLASGOW (MedPage Today) -- Only 15% of fibromyalgia patients in a small study had adequate levels of vitamin D, suggesting implications for treatment. Read More

COX-2 Mystery Cleared Up (CME/CE)

(MedPage Today) -- A controversial class of anti-inflammatory drugs -- the COX-2 inhibitors -- increase the risk of cardiovascular disease by blocking a key protective substance, researchers reported. Read More

IL-17 Blocker Promising for Spondylitis (CME/CE)

GLASGOW (MedPage Today) -- A new monoclonal antibody that targets the interleukin (IL)-17 pathway appeared promising for the treatment of ankylosing spondylitis in a proof-of-concept study presented here. Read More

Lacosamide Good in Trigeminal Neuralgia

NEW ORLEANS (MedPage Today) -- The anti-epileptic agent lacosamide (Vimpat) appears to give relief to patients with refractory trigeminal neuralgia, researchers reported here. Read More

'Visual Snow' Called Real, Not Drug Related

NEW ORLEANS (MedPage Today) -- A mysterious and troubling phenomenon called "visual snow" is a distinct syndrome that does not appear to stem from illicit drug use, nor is it a migraine aura, a researcher said here. Read More

Latest Use for Botox: Teeth Grinding

NEW ORLEANS (MedPage Today) -- Patients who ground their teeth so hard during sleep that they required medical attention achieved significant relief from botulinum toxin shots, researchers said here. Read More

Optogenetics project takes top NIDA Addiction Science Award

A project that maps dopamine circuits in the prefrontal cortex through optogenetic manipulation was given top honors in this year’s annual Addiction Science Awards at the 2012 Intel International Science and Engineering Fair (ISEF) -- the world's largest science competition for high school students. The awards were presented by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and Friends of NIDA, a coalition that supports NIDA’s mission. The Intel ISEF Addiction Science Awards were presented at a ceremony Thursday night at the David L. Lawrence Convention Center in Pittsburgh. Read More

NIH-led study finds genetic test results do not trigger increased use of health services

People have increasing opportunities to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up or diminish test recipients’ demand for potentially costly follow-up health services, according to a study performed by researchers at the National Institutes of Health and colleagues at other institutions. Read More

NIH study finds that coffee drinkers have lower risk of death

Older adults who drank coffee -- caffeinated or decaffeinated -- had a lower risk of death overall than others who did not drink coffee, according a study by researchers from the National Cancer Institute (NCI), part of the National Institutes of Health, and AARP. Read More

Paralyzed individuals use thought-controlled robotic arm to reach and grasp

In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own -- for the first time in nearly 15 years -- by using her thoughts to direct a robotic arm. The trial, funded in part by the National Institutes of Health, is evaluating the safety and feasibility of an investigational device called the BrainGate neural interface system. Read More

NIH-funded research provides new clues on how ApoE4 affects Alzheimer's risk

Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of ApoE damages the blood vessels that feed the brain. Read More

NINR welcomes five new members to the National Advisory Council for Nursing Research

The National Institute of Nursing Research (NINR) announces five new members to the National Advisory Council for Nursing Research (NACNR), the institute's principal advisory board. Members of the council are drawn from the scientific and lay communities, embodying a diverse perspective from the fields of nursing, public and health policy, law, and economics. NINR, a component of the National Institutes of Health, is the primary federal agency for the support of nursing research. Read More

NIH statement on HIV Vaccine Awareness Day - May 18, 2012

There is a growing consensus that we can significantly curtail the HIV/AIDS pandemic by implementing scientifically proven HIV prevention strategies, such as voluntary medically supervised adult male circumcision, prevention of mother-to-child transmission and treatment as prevention. Read More